Key terms
About SANA
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SANA news
Mar 01
4:10pm ET
Sana Biotechnology files automatic mixed securities shelf
Mar 01
6:29am ET
Sana Biotechnology: Buy Rating Affirmed Amid Anticipation of Clinical Breakthroughs and Hypoimmune Platform Validation
Mar 01
6:28am ET
Sana Biotechnology: Promising Clinical Prospects and Buy Rating Justified by Upcoming Data Readouts
Mar 01
6:21am ET
Sana Biotechnology price target raised to $15 from $8 at JMP Securities
Mar 01
12:30am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Feb 29
8:20pm ET
Analysts Offer Insights on Healthcare Companies: Privia Health Group (PRVA) and Sana Biotechnology (SANA)
Feb 29
4:15pm ET
Sana Biotechnology reports Q4 EPS (45c), consensus (38c)
Feb 16
8:06am ET
Viridian Therapeutics names Jennifer Tousignant chief legal officer
Feb 15
6:20am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Feb 13
4:47pm ET
Sana Biotechnology publishes HIP-modified pancreatic islet cells data
Feb 09
5:16am ET
Sana Biotechnology Announces Pricing of Upcoming Offering
Feb 09
5:15am ET
Sana Biotechnology’s Major Public Offering Agreement
Feb 08
6:04am ET
Sana Biotechnology 17.3M share Spot Secondary priced at $5.50
Feb 08
4:35am ET
Sana Biotechnology Previews Preliminary Financials and Trial Progress
Feb 07
4:03pm ET
Sana Biotechnology announces $125M common stock offering
Jan 11
6:40am ET
Analysts Are Bullish on These Healthcare Stocks: Masimo (MASI), Sana Biotechnology (SANA)
Jan 10
10:01am ET
Sana Biotechnology trading resumes
Jan 10
9:56am ET
Sana Biotechnology trading halted, volatility trading pause
Jan 05
9:04am ET
Sana Biotechnology announces FDA clearance of IND application for SC262
Dec 12
12:26am ET
Buy Rating for Sana Biotechnology Amidst Promising Developments and Strong Financials
Dec 11
9:08am ET
Sana Biotechnology highlights preclinical data on allogeneic CAR T cells
No recent news articles are available for SANA
No recent press releases are available for SANA
SANA Financials
Key terms
Ad Feedback
SANA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SANA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range